Literature DB >> 27647467

Predictors of voiding dysfunction following extensive vaginal pelvic reconstructive surgery.

Tsia-Shu Lo1,2,3, Nagashu Shailaja4,5, Wu-Chiao Hsieh4, Ma Clarissa Uy-Patrimonio4,6, Faridah Mohd Yusoff4,7, Rami Ibrahim4,8.   

Abstract

INTRODUCTION AND HYPOTHESIS: The objective of this study was to identify the predictors of postoperative voiding dysfunction in women following extensive vaginal pelvic reconstructive surgery.
METHODS: We enrolled 1,425 women who had pelvic organ prolapse of POP-Q stage III or IV and had undergone vaginal pelvic reconstructive surgery with or without transvaginal mesh insertion from January 2006 to December 2014. All subjects were required to complete a 72-h voiding diary, and the IIQ-7, UDI-6, POPDI-6 and PISQ-12 questionnaires. Urodynamic study was performed preoperatively and postoperatively.
RESULTS: Of the 1,425 women, 54 were excluded due to incomplete data, and 1,017 of the remaining 1,371 (74.2 %) had transvaginal mesh surgery and 247 (18 %) had concurrent midurethral sling insertion. Of 380 women (27.7 %) with preoperative voiding dysfunction, 37 (9.7 %) continued to have voiding dysfunction postoperatively. Of the remaining 991 women (72.3 %) with normal preoperative voiding function, 11 (1.1 %) developed de novo voiding dysfunction postoperatively. The overall incidence of postoperative voiding dysfunction was 3.5 % (48/1,371). Those with concurrent midurethral sling insertion were at higher risk of developing voiding dysfunction postoperatively (OR 3.12, 95 % CI 1.79 - 5.46, p < 0.001). Diabetes mellitus, preoperative detrusor pressure at maximal flow (Dmax) <10 cm H2O and postvoid residual volume ≥200 ml were significant risk factors for the development of postoperative voiding dysfunction (OR 3.07, 1.84 and 2.15, respectively; 95 % CI 1.69 - 5.60, 1.39 - 2.91 and 1.10 - 3.21, respectively).
CONCLUSIONS: Diabetes mellitus, concurrent midurethral sling insertion, preoperative Dmax <10 cm H2O and postvoid residual volume ≥200 ml in patients with advanced pelvic organ prolapse were risk factors for the development of postoperative voiding dysfunction after vaginal pelvic reconstructive surgery. Therefore, counseling is worthwhile before considering vaginal pelvic reconstructive surgery.

Entities:  

Keywords:  Dmax; Post void residue (PVR); Voiding dysfunction

Mesh:

Year:  2016        PMID: 27647467     DOI: 10.1007/s00192-016-3144-z

Source DB:  PubMed          Journal:  Int Urogynecol J        ISSN: 0937-3462            Impact factor:   2.894


  26 in total

1.  Incidence of stress urinary incontinence following vaginal repair of pelvic organ prolapse in objectively continent women.

Authors:  Hazem Al-Mandeel; Sue Ross; Magali Robert; Jill Milne
Journal:  Neurourol Urodyn       Date:  2011-01-31       Impact factor: 2.696

2.  Comparison between Elevate anterior/apical system and Perigee system in pelvic organ prolapse surgery: clinical and sonographic outcomes.

Authors:  Tsia-Shu Lo; Nazura Bt Karim; Eileen Feliz M Cortes; Pei-Ying Wu; Yi-Hao Lin; Yiap Loong Tan
Journal:  Int Urogynecol J       Date:  2014-09-26       Impact factor: 2.894

Review 3.  Voiding dysfunction due to detrusor underactivity: an overview.

Authors:  Marcus J Drake; Jonathan Williams; Dominika A Bijos
Journal:  Nat Rev Urol       Date:  2014-07-08       Impact factor: 14.432

4.  Combined anterior trans-obturator mesh and sacrospinous ligament fixation in women with severe prolapse--a case series of 30 months follow-up.

Authors:  Tsia-Shu Lo; Kiran Ashok
Journal:  Int Urogynecol J       Date:  2010-11-04       Impact factor: 2.894

5.  One-year outcome of concurrent anterior and posterior transvaginal mesh surgery for treatment of advanced urogenital prolapse: case series.

Authors:  Tsia-Shu Lo
Journal:  J Minim Invasive Gynecol       Date:  2010-05-23       Impact factor: 4.137

Review 6.  Classification of neurogenic voiding dysfunction.

Authors:  A J Wein
Journal:  J Urol       Date:  1981-05       Impact factor: 7.450

Review 7.  Bladder dysfunction in patients with diabetes.

Authors:  Christopher S Gomez; Prashanth Kanagarajah; Angelo E Gousse
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

8.  Videourodynamic analysis of pathophysiology of men with both storage and voiding lower urinary tract symptoms.

Authors:  Hann-Chorng Kuo
Journal:  Urology       Date:  2007-08       Impact factor: 2.649

Review 9.  An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.

Authors:  Bernard T Haylen; Dirk de Ridder; Robert M Freeman; Steven E Swift; Bary Berghmans; Joseph Lee; Ash Monga; Eckhard Petri; Diaa E Rizk; Peter K Sand; Gabriel N Schaer
Journal:  Int Urogynecol J       Date:  2009-11-25       Impact factor: 2.894

10.  Long-term outcomes of synthetic transobturator nonabsorbable anterior mesh versus anterior colporrhaphy in symptomatic, advanced pelvic organ prolapse surgery.

Authors:  Tsia-Shu Lo; Leng Boi Pue; Yiap Loong Tan; Pei-Ying Wu
Journal:  Int Urogynecol J       Date:  2013-08-14       Impact factor: 2.894

View more
  11 in total

Review 1.  A systematic review comparing early with late removal of indwelling urinary catheters after pelvic organ prolapse surgery.

Authors:  Nansha Xie; Zeyin Hu; Zengjie Ye; Qiong Xu; Jie Chen; Yan Lin
Journal:  Int Urogynecol J       Date:  2020-09-04       Impact factor: 2.894

2.  Changes in voiding function after laparoscopic sacrocolpopexy for advanced pelvic organ prolapse: a cohort study of 76 cases.

Authors:  Xiao-Chen Song; Lan Zhu; Shuo Liang; Tao Xu
Journal:  Int Urogynecol J       Date:  2017-07-18       Impact factor: 2.894

3.  Towards conservative treatment for stress urinary incontinence and pelvic organ prolapse: An Asian perspective footnote from the Pan-Asia meeting.

Authors:  Tsia-Shu Lo; Yiap Loong Tan
Journal:  Int Urogynecol J       Date:  2022-08-10       Impact factor: 1.932

4.  Postoperative void trial failure and same-day discharge following apical pelvic organ prolapse surgery: a retrospective matched case-control study.

Authors:  James H Ross; Shannon L Wallace; Cecile A Ferrando
Journal:  Int Urogynecol J       Date:  2022-08-31       Impact factor: 1.932

5.  The efficacy of force of stream assessment for post-operative catheter management: a retrospective cohort study.

Authors:  Obey Albaini; Stephanie Farah; Karl Jallad
Journal:  Int Urogynecol J       Date:  2022-04-22       Impact factor: 1.932

6.  International Urogynecology Consultation Chapter 1 Committee 5: relationship of pelvic organ prolapse to associated pelvic floor dysfunction symptoms: lower urinary tract, bowel, sexual dysfunction and abdominopelvic pain.

Authors:  Marie-Andrée Harvey; Hui Ju Chih; Roxana Geoffrion; Baharak Amir; Alka Bhide; Pawel Miotla; Peter F W M Rosier; Ifeoma Offiah; Manidip Pal; Alexandriah Nicole Alas
Journal:  Int Urogynecol J       Date:  2021-08-02       Impact factor: 2.894

7.  Anterior-apical single-incision mesh surgery (uphold): 1-year outcomes on lower urinary tract symptoms, anatomy and ultrasonography.

Authors:  Tsia-Shu Lo; Leng Boi Pue; Yiap Loong Tan; Wu-Chiao Hsieh; Chuan Chi Kao; Ma Clarissa Uy-Patrimonio
Journal:  Int Urogynecol J       Date:  2018-07-14       Impact factor: 2.894

8.  Prophylactic midurethral sling insertion during transvaginal pelvic reconstructive surgery for advanced prolapse patients with high-risk predictors of postoperative de novo stress urinary incontinence.

Authors:  Tsia-Shu Lo; Sandy Chua; Chuan Chi Kao; Wu-Chiao Hsieh; Ming-Ping Wu; Ling-Hong Tseng
Journal:  Int Urogynecol J       Date:  2018-10-18       Impact factor: 2.894

9.  Functional brain imaging in voiding dysfunction.

Authors:  Rose Khavari; Timothy B Boone
Journal:  Curr Bladder Dysfunct Rep       Date:  2019-02-08

10.  Does Pharmacological Treatment Reduce the Incidence of Lower Urinary Tract Symptoms (LUTS) after Transobturator Sling?

Authors:  Tomasz Rechberger; Andrzej Wrobel; Alicja Zietek; Ewa Rechberger; Beata Kulik-Rechberger; Michal Bogusiewicz; Pawel Miotla
Journal:  Biomed Res Int       Date:  2019-03-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.